@article{Daynes_E-2023_110979,
title = {The effect of COVID rehabilitation for ongoing symptoms Post HOSPitalisation with COVID-19 (PHOSP-R):protocol for a randomised parallel group controlled trial on behalf of the PHOSP consortium},
author = {Daynes, E. and Baldwin, M. and Greening, N. and Yates, T. and Bishop, N. and Mills, G. and Hamrouni, M. and Plekhanova, T. and Vogiatzis, I. and Echevarria, C. and Nathu, R. and McAuley, H. and Latimer, L. and Glennie, J. and Chambers, F. and Penfold, R. and Hume, E. and Magaritis, D. and Alexiou, C. and Potthoff, S. and Hogg, M. and Haighton, C. and Nichol, B. and Leavy, O. and Richardson, M. and Elneima, O. and Singapuri, A. and Sereno, M. and Saunders, R. and Harris, V. and Nolan, C. and Bolton, C. and Houchen-Wolloff, L. and Harrison, E. and Lone, N. and Quint, J. and Chalmers, J. and Ho, L. and Horsley, A. and Marks, M. and Poinasamy, K. and Ramen, B. and Wain, L. and Brightling, C. and Man, W. and Evans, R. and Singh, S.},
month = {jan},
year = {2023},
abstract = {INTRODUCTION: Many adults hospitalised with COVID-19 have persistent symptoms such as fatigue, breathlessness and brain fog that limit day-to-day activities. These symptoms can last over 2 years. Whilst there is limited controlled studies on interventions that can support those with ongoing symptoms, there has been some promise in rehabilitation interventions in improving function and symptoms either using face-to-face or digital methods, but evidence remains limited and these studies often lack a control group.},
volume = {24},
journal = {Trials},
publisher = {Springer Nature},
url = {https://doi.org/10.1186/s13063-023-07093-7},
}
